FDA Authorizes Pfizer-BioNTech COVID 19 for Children 5 to 11
The Food and Drug Administration on Friday authorized Pfizer-BioNTech’s lower-dose Covid-19 vaccine for children ages 5 to 11, making it available to 28 million children in the United States.
The FDA’s move comes several days after its advisory committee voted 17-0, with one abstention, in favor of recommending the vaccine for children. The committee concluded that the benefits of vaccination outweigh its risks.
In a presentation to the FDA on Tuesday, Pfizer said its vaccine was nearly 91 percent effective at preventing symptomatic illness in children, adding that it appears to hold up well against the highly transmissible delta variant.
https://www.nbcnews.com/health/health-news/fda-authorizes-pfizer-vaccine-kids-5-11-rcna3892
